Precision Neuroscience Partners with SCI Ventures to Advance Brain–Computer Interfaces for People with Paralysis

Precision Neuroscience has announced a new investment partnership with SCI Ventures, the world’s first specialist venture fund dedicated to paralysis. The collaboration aims to accelerate the company’s mission to restore communication and independence to people affected by paralysis and other neurological conditions through brain–computer interface (BCI) technologies.

SCI Ventures is supported by leading foundations in the United States, the United Kingdom, and the European Union, including the Christopher & Dana Reeve Foundation, Wings for Life, Spinal Research, Promobilia, and the Shepherd Center. Its investment underscores growing confidence in Precision’s approach to BCI innovation and its potential to improve the quality of life for millions of people worldwide affected by spinal cord injury.

Brain–computer interfaces represent an emerging class of neurotechnology that translates brain signals into digital commands, enabling individuals with paralysis to interact with computers, communicate, and control assistive devices through thought alone. Precision’s flagship product, the Layer 7 Cortical Interface, recently received FDA clearance. This non-penetrating device allows for safer and more scalable deployment than traditional implantable BCIs.

Adrien Cohen, Founding Managing Director of SCI Ventures, said, “We’re excited to support Precision Neuroscience as part of a broader wave of innovators pushing brain–computer interface technologies toward real-world clinical impact. Precision stands out for its focus on less invasive solutions and its momentum in translating BCI from lab to bedside—a critical step in making these technologies truly accessible to people living with paralysis.”

Michael Mager, co-founder and CEO of Precision Neuroscience, added, “The support of SCI Ventures, backed by the Reeve Foundation and other leaders in spinal cord injury advocacy, gives us added momentum at a pivotal time for brain–computer interfaces. People living with paralysis deserve solutions that are safe, effective, and practical to deliver at scale. With SCI Ventures as a partner, we’re one step closer to bringing this transformative technology to those who need it.”